Pharmaceuticals (Basel, Switzerland)

ISSN	1424-8247
ISSN-L	1424-8247
IUID	2e064109548f499e974eb5ab28f0fbea
Modified	2020-11-27T13:12:53.623Z
Created	2020-10-06T13:52:05.793Z

Year 2025

PubMed DOI Crossref

Ga-68-Labeled Affibody Molecule-Based Radiopharmaceutical Targeting Platelet Derived Growth Factor Receptor Beta for Detection of Active Fibrosis in Patients with Myocardial Infarction.

Velikyan I, Grinnemo KH, Flodin V, ..., Korsgren O, Eriksson O

Pharmaceuticals (Basel, Switzerland) 18 (12) - [2025-12-01; online 2025-12-01]

PubMed DOI Crossref

Design, Synthesis, and Computational Evaluation of 3,4-Dihydroquinolin-2(1H)-One Analogues as Potential VEGFR2 Inhibitors in Glioblastoma Multiforme.

Buhlak S, Abad N, Akachar J, ..., Türkez H, Mardinoglu A

Pharmaceuticals (Basel, Switzerland) 18 (2) - [2025-02-08; online 2025-02-08]

Year 2023

PubMed DOI Crossref

Lysicamine Reduces Protein Kinase B (AKT) Activation and Promotes Necrosis in Anaplastic Thyroid Cancer.

Rodrigues MT, Michelli APP, Caso GF, ..., Calil-Silveira J, Rubio IGS

Pharmaceuticals (Basel, Switzerland) 16 (12) - [2023-12-04; online 2023-12-04]

PubMed DOI Crossref

Radiotracers for Imaging of Fibrosis: Advances during the Last Two Decades and Future Directions.

Eriksson O, Velikyan I

Pharmaceuticals (Basel, Switzerland) 16 (11) - [2023-11-01; online 2023-11-01]

PubMed DOI Crossref

Exploration of Novel Urolithin C Derivatives as Non-Competitive Inhibitors of Liver Pyruvate Kinase.

Battisti UM, Monjas L, Akladios F, ..., Mardinoğlu A, Grøtli M

Pharmaceuticals (Basel, Switzerland) 16 (5) - [2023-04-28; online 2023-04-28]

Adil Mardinoglu SciLifeLab Fellow

Year 2022

PubMed DOI Crossref

Imaging of the Glucose-Dependent Insulinotropic Polypeptide Receptor Using a Novel Radiolabeled Peptide Rationally Designed Based on Endogenous GIP and Synthetic Exendin-4 Sequences.

Velikyan I, Bossart M, Haack T, ..., Wagner M, Eriksson O

Pharmaceuticals (Basel, Switzerland) 16 (1) - [2022-12-31; online 2022-12-31]

Olof Eriksson SciLifeLab Fellow

Year 2021

PubMed DOI Crossref

Improved Radiolytic Stability of a 68Ga-labelled Collagelin Analogue for the Imaging of Fibrosis.

Velikyan I, Rosenström U, Rosestedt M, Eriksson O, Antoni G

Pharmaceuticals (Basel, Switzerland) 14 (10) - [2021-09-28; online 2021-09-28]

Olof Eriksson SciLifeLab Fellow

PubMed DOI Crossref

Targeting Loss of Heterozygosity: A Novel Paradigm for Cancer Therapy.

Zhang X, Sjöblom T

Pharmaceuticals (Basel, Switzerland) 14 (1) - [2021-01-13; online 2021-01-13]

Year 2020

PubMed DOI Crossref

Automated GMP-Compliant Production of [68Ga]Ga-DO3A-Tuna-2 for PET Microdosing Studies of the Glucagon Receptor in Humans.

Wagner M, Doverfjord JG, Tillner J, ..., Eriksson O, Velikyan I

Pharmaceuticals (Basel, Switzerland) 13 (8) 176 [2020-07-31; online 2020-07-31]

Olof Eriksson SciLifeLab Fellow

PubMed DOI Crossref

(Radio)Theranostic Patient Management in Oncology Exemplified by Neuroendocrine Neoplasms, Prostate Cancer, and Breast Cancer.

Velikyan I

Pharmaceuticals (Basel, Switzerland) 13 (3) - [2020-03-05; online 2020-03-05]

PubMed DOI Crossref

Structure-Activity Relationships (SARs) of α-Ketothioamides as Inhibitors of Phosphoglycerate Dehydrogenase (PHGDH).

Spillier Q, Ravez S, Unterlass J, ..., Feron O, Frédérick R

Pharmaceuticals (Basel, Switzerland) 13 (2) - [2020-01-22; online 2020-01-22]

Year 2016

PubMed DOI Crossref

Feasibility of Multiple Examinations Using (68)Ga-Labelled Collagelin Analogues: Organ Distribution in Rat for Extrapolation to Human Organ and Whole-Body Radiation Dosimetry.

Velikyan I, Rosenström U, Bulenga TN, Eriksson O, Antoni G

Pharmaceuticals (Basel, Switzerland) 9 (2) - [2016-06-06; online 2016-06-06]

Olof Eriksson SciLifeLab Fellow

SciLifeLab Data Centre

Publications 9.5.1